Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours Β· Estimated delivery Aug 11 - Aug 16
Concentration 2 mg/mL Draw volume 0.125 mL Units (U-100) 12.5 Doses per vial 20 Reference preset 5mg 2.5mL 0.25mg Reference values from the default preset adjust the calculator below for your vial
In recent years, two trials tested the first-generation ACI for the more challenging OA disease
/ Guangzhou Innogen Pharmaceutical Group Co., Ltd., Novo Nordisk A/S, PegBio Co., Ltd., Pfizer Inc., QL Biopharmaceutical Co., Ltd., Roche Holding AG, Sanofi S.A., Sciwind Biosciences Co., Ltd., Tonghua Dongbao Pharmaceutical Co., Ltd., Viking Therapeutics, Inc., Amgen Inc., BioLingus GmbH, D&D Pharmatech Inc., Gmax Biopharm LLC, Hanmi Pharmaceutical Co., Ltd., Vivani Medical, Inc., vTv Therapeutics Inc., Zealand Pharma A/S, Altimmune, Inc., Structure Therapeutics Inc
Pharmacokinetics Absorption The absolute bioavailability of tesamorelin after subcutaneous administration of a 2 mg dose was determined to be less than 4% in healthy adult subjects
Edmonds R, Steffen V, Honigberg LA, Chang MC
US$ 20.38
US$ 26.81
US$ 27.92
US$ 21.09
